Deep In-House Actuarial Services to Guide Your Plan
When it comes to managing rising healthcare costs, Alera Group offers the actuarial and finance expertise you can count on to optimize your benefits plan and drive value to your organization and employees.
Alera Group’s dedicated actuarial team can help you:
- Develop program strategy with a long-term view of costs and potential claims liability
- Determine the impact of program and vendor changes
- Set program budgets for planning and reporting, and monitor emerging experience against budget
- Analyze claims experience and population health trends
- Support for retiree plans, including an analysis of creditable coverage, retiree drug subsidy (RDS) attestations and actuarial valuations.
Financial Management Approach
Alera Group offers comprehensive financial management services and analysis across all aspects of your benefits program, including:
Program Strategy
Develop a baseline of long-term costs and potential cost variability. Assess the potential impact of a program strategy and vendor changes and conduct a risk assessment.
Cost Projections
Develop and update budget projections, set rates and provide long-term cost projections.
Plan Governance
Provide regular monitoring and an executive dashboard, identify key cost drivers and conduct large claims reporting.
Financial Reporting & Reserving
Establish incurred but not paid (IBNP) reserve, conduct retiree medical valuations and provide quarterly financial reporting support.
COVID-19 and Mental Health Trends
Managing rising numbers.
COVID-19 and Utilization
Impact on usage, spending and strategies.
EXPERT EDUCATION
Events and Webinars
Employee Benefits
Driving Communications and Engagement: Open Enrollment
Our experts will walk you through a strategic planning process to make sure you’re sharing in a way that not only drives employee awareness and engagement but also reaches your workforce across platforms with what they need to know about choosing the right benefits for them and their families.
August 15, 2024 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
Q3 Compliance Update
Alera Group's quarterly employee benefits compliance roundup will help you stay current on the latest national regulatory developments impacting employers.
September 3, 2024 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
Is Tech-Enabled Brokerage Right for You?
Our experts will lay out what tech-enabled brokerage is, how it works and why it makes sense for the right organizations.
September 19, 2024 at 01:00 pm CT | Virtual
Sign Up
THOUGHT LEADERSHIP
Insights
Employee Benefits
Benefits Benchmarking Webinar: What To Do With the Data
If you’re designing your company’s employee benefits program, you want to know what your peers and competitors are offering. Employee retention and talent acquisition are largely dependent on whether you offer a benefits package that meets or exceeds the standards of your industry, location and company size while managing costs in an increasingly expensive market for healthcare and pharmaceuticals. That’s why Alera Group places a high priority on using benchmarking data and analysis to inform and otherwise serve our clients.
July 1, 2024
Find out more
Employee Benefits
How To Lower Healthcare Costs While Improving Benefit Offerings
Join us on June 20 for a one-hour webinar designed to help you eliminate wasteful healthcare spending while providing your employees with benefits that attract and retain talent. We’ll take you through our three-step solution.
June 11, 2024
Find out more Employee Benefits
Legal Alert: PCORI Fees Due by July 31, 2024
Employers that sponsor self-insured group health plans, including health reimbursement arrangements (HRAs) should keep in mind the upcoming July 31, 2024, deadline for paying fees that fund the Patient-Centered Outcomes Research Institute (PCORI) via Form 720, which was recently updated and released by the IRS.
June 7, 2024
Find out more Employee Benefits
Legal Alert: CMS Redesigns the Medicare Part D Prescription Drug Program Beginning in 2025
As a result of the changes to Medicare Part D under §11201 of the Inflation Reduction Act of 2022, on April 1, 2024, CMS released Final Redesign Program Instructions (“Final Program Instructions”) for the Medicare Part D prescription drug program, which are effective starting in 2025.
May 30, 2024
Find out more